Evidence map›Paper›PMID 42032214›Full record

ArticleScientific reports2026

Development and validation of a machine learning model for predicting positive blood cultures using vital signs in ICU patients.

Issei Seike, Hiroaki Baba, Shinya Sonobe, Junya Iwazaki, Makoto Miyauchi, Tomoya Kobayashi, Eichi Takaya, Saori Ikumi, Taro Miyamoto, Shota Kawamoto and 6 more

Abstract readValidation Study
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Issei SeikeDepartment of Clinical Infectious Diseases, Internal Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan.
Hiroaki BabaDepartment of Clinical Infectious Diseases, Internal Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan.
Shinya SonobeAI Lab, Tohoku University Hospital, 1-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8574, Japan. shinya.sonobe.d7@tohoku.ac.jp.
Junya IwazakiAI Lab, Tohoku University Hospital, 1-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8574, Japan.
Makoto MiyauchiAI Lab, Tohoku University Hospital, 1-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8574, Japan.
Tomoya KobayashiAI Lab, Tohoku University Hospital, 1-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8574, Japan.
Eichi TakayaAI Lab, Tohoku University Hospital, 1-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8574, Japan.
Saori IkumiAI Lab, Tohoku University Hospital, 1-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8574, Japan.
Taro MiyamotoAI Lab, Tohoku University Hospital, 1-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8574, Japan.
Shota KawamotoAI Lab, Tohoku University Hospital, 1-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8574, Japan.
Shintaro OyamaInnovative Research Center for Preventive Medical Engineering, Institute of Innovation for Future Society, Nagoya University, Tokai National Higher Education and Research System, Nagoya, Aichi, Japan.
Takahiro ImaizumiDepartment of Advanced Medicine, Nagoya University Hospital, Tokai National Higher Education and Research System, Nagoya, Japan.
Akemi MorohashiDepartment of Advanced Medicine, Nagoya University Hospital, Tokai National Higher Education and Research System, Nagoya, Japan.
Kengo OshimaDepartment of Clinical Infectious Diseases, Internal Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan.
Asami NakayamaDepartment of Clinical Infectious Diseases, Internal Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan.
Tetsuji AoyagiDepartment of Clinical Infectious Diseases, Internal Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bloodstream infections require timely and appropriate diagnosis and treatment, as inadequate management is associated with higher mortality. Previous predictive models for bloodstream infection have generally incorporated laboratory test results in addition to vital signs, although laboratory results are not always immediately available in clinical practice. This study aimed to develop and validate a machine learning model to predict positive blood cultures using only vital signs in febrile intensive care unit (ICU) patients (maximum BT ≥ 38 °C). Clinical data from ICU patients at two university hospitals were included, with 597 blood cultures used for model development and 366 for external validation. Six explanatory variables derived from body temperature, heart rate, and mean arterial pressure measured over three days were used to construct a Balanced Random Forest model. The area under the receiver operating characteristic curve was 0.700 ± 0.072 for internal validation and 0.679 ± 0.010 for external validation. SHapley Additive exPlanations value analysis indicated that a larger temperature range contributed to positive predictions, while no increase in temperature, increases in blood pressure, and a decrease in heart rate contributed to negative predictions. The model demonstrates moderate predictive performance and shows comparable results across different datasets. It can continuously monitor the need for blood cultures, thereby serving as an adjunctive tool to support clinical decision-making.

Indexed as

Blood CultureIntensive Care UnitsMachine LearningSepsisVital SignsAgedBody TemperatureClassification AlgorithmsFemaleHeart RateHumansMaleMiddle AgedPrediction AlgorithmsPredictive Learning ModelsRandom ForestArtificial intelligenceBlood cultureBloodstream infectionIntensive care unitMachine learningVital signs

Identifiers

PMID42032214
PMCPMC13280142

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.